Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
MoonLake Immunotherapeutics' stock took a 6% hit after announcing a secondary share issue. Was this a necessary move or a misstep? We break down the implications.